GlobeNewswire: Neos Therapeutics, Inc. Contains the last 10 of 106 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T16:00:08ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2021/03/12/2192137/0/en/Glass-Lewis-a-Leading-Independent-Proxy-Advisory-Firm-Recommends-Neos-Therapeutics-Stockholders-Vote-FOR-the-Pending-Merger-With-Aytu-BioScience.html?f=22&fvtc=4&fvtv=26659Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience2021-03-12T14:04:16Z<![CDATA[– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time –]]>https://www.globenewswire.com/news-release/2021/03/10/2190770/0/en/Leading-Independent-Proxy-Advisory-Firm-ISS-Recommends-Neos-Therapeutics-Stockholders-Vote-FOR-the-Pending-Merger-With-Aytu-BioScience.html?f=22&fvtc=4&fvtv=26659Leading Independent Proxy Advisory Firm ISS Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience2021-03-10T21:01:00Z<![CDATA[– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time –]]>https://www.globenewswire.com/news-release/2021/02/10/2173138/0/en/Aytu-BioScience-and-Neos-Therapeutics-Announce-Special-Meetings-of-Stockholders-Related-to-Proposed-Merger-to-Be-Held-on-March-18-2021.html?f=22&fvtc=4&fvtv=26659Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 20212021-02-10T13:00:00Z<![CDATA[– Record date for each Special Meeting of Stockholders is February 5, 2021 –]]>https://www.globenewswire.com/news-release/2021/01/04/2152920/0/en/Neos-Therapeutics-to-Present-at-H-C-Wainwright-Virtual-BioConnect-Conference.html?f=22&fvtc=4&fvtv=26659Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference2021-01-04T21:01:00Z<![CDATA[DALLAS and FORT WORTH, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a pre-recorded presentation as part of the H.C. Wainwright Virtual BioConnect Conference.]]>https://www.globenewswire.com/news-release/2020/12/10/2143034/0/en/Aytu-BioScience-and-Neos-Therapeutics-Announce-Definitive-Merger-Agreement-Creating-a-Combined-100M-Revenue-Specialty-Pharmaceutical-Company.html?f=22&fvtc=4&fvtv=26659Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company2020-12-10T13:00:00Z<![CDATA[ENGLEWOOD, Colo. and GRAND PRAIRIE, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, and Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that they have entered into a definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.]]>https://www.globenewswire.com/news-release/2020/11/09/2122598/0/en/Neos-Therapeutics-Reports-Third-Quarter-2020-Financial-Results.html?f=22&fvtc=4&fvtv=26659Neos Therapeutics Reports Third Quarter 2020 Financial Results2020-11-09T12:00:00Z<![CDATA[– Company to host conference call today at 8:30 a.m. EDT – – Company to host conference call today at 8:30 a.m. EDT –]]>https://www.globenewswire.com/news-release/2020/11/02/2118382/0/en/Neos-Therapeutics-to-Host-Third-Quarter-2020-Financial-and-Operating-Results-Conference-Call-on-November-9th-2020.html?f=22&fvtc=4&fvtv=26659Neos Therapeutics to Host Third Quarter 2020 Financial and Operating Results Conference Call on November 9th, 20202020-11-02T13:00:00Z<![CDATA[DALLAS and FORT WORTH, Texas, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its third quarter 2020 financial results at the opening of U.S. financial markets on Monday, November 9, 2020. Neos management will host a conference call and live audio webcast to discuss these results and provide a company update at 8:30 a.m. ET that same day.]]>https://www.globenewswire.com/news-release/2020/09/09/2090826/0/en/Neos-Therapeutics-to-Present-at-Cantor-Virtual-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=26659Neos Therapeutics to Present at Cantor Virtual Global Healthcare Conference2020-09-09T12:00:00Z<![CDATA[DALLAS and FORT WORTH, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020, at 3:40 p.m. ET.]]>https://www.globenewswire.com/news-release/2020/08/10/2075485/0/en/Neos-Therapeutics-Reports-Second-Quarter-2020-Financial-Results.html?f=22&fvtc=4&fvtv=26659Neos Therapeutics Reports Second Quarter 2020 Financial Results2020-08-10T11:00:00Z<![CDATA[– Company to host conference call today at 8:30 a.m. EDT – – Company to host conference call today at 8:30 a.m. EDT –]]>https://www.globenewswire.com/news-release/2020/08/03/2071651/0/en/Neos-Therapeutics-to-Host-Second-Quarter-2020-Financial-and-Operating-Results-Conference-Call-on-August-10th-2020.html?f=22&fvtc=4&fvtv=26659Neos Therapeutics to Host Second Quarter 2020 Financial and Operating Results Conference Call on August 10th, 20202020-08-03T12:00:00Z<![CDATA[DALLAS and FORT WORTH, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its second quarter 2020 financial results at the opening of U.S. financial markets on Monday, August 10, 2020. Neos management will host a conference call and live audio webcast to discuss these results and provide a company update at 8:30 a.m. ET that same day.]]>